[BPMC] Blueprint Medicines Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 28.15 Change: 1.24 (4.61%)
Ext. hours: Change: 0 (0%)

chart BPMC

Refresh chart

Strongest Trends Summary For BPMC

BPMC is in the long-term up 224% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-550 K Cash From Investing Activities-1.28 M Cash From Operating Activities4.89 M Gross Profit
Net Profit-11.57 M Operating Profit-11.35 M Total Assets55.91 M Total Current Assets52.18 M
Total Current Liabilities14.63 M Total Debt8.65 M Total Liabilities31.19 M Total Revenue650 K
Technical Data
High 52 week86.6 Low 52 week45.57 Last close81.3 Last change0.26%
RSI53.58 Average true range4.54 Beta1.49 Volume291.22 K
Simple moving average 20 days4.47% Simple moving average 50 days1.7% Simple moving average 200 days15.69%
Performance Data
Performance Week-2.82% Performance Month10.27% Performance Quart6.85% Performance Half35.03%
Performance Year-5.88% Performance Year-to-date50.81% Volatility daily3.98% Volatility weekly8.9%
Volatility monthly18.24% Volatility yearly63.17% Relative Volume181.66% Average Volume495.51 K
New High New Low

News

2019-06-15 06:00:00 | Blueprint Medicines Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress

2019-06-14 08:45:00 | Blueprint Medicines Submits New Drug Application to U.S. Food and Drug Administration for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST

2019-06-04 08:03:46 | See what the IHS Markit Score report has to say about Blueprint Medicines Corp.

2019-06-03 16:24:31 | Who Are The Winners And Losers From The Year's Biggest Cancer Meeting?

2019-06-03 10:26:02 | Blueprint Medicines' NDA for Avapritinib on Track for GIST

2019-06-03 09:00:00 | Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019

2019-06-01 09:00:00 | Blueprint Medicines Presents NAVIGATOR Trial Data in PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST at ASCO 2019 Supporting Planned Marketing Applications for Avapritinib

2019-05-29 16:00:00 | Blueprint Medicines to Present at Upcoming Investor Conferences in June

2019-05-23 19:26:00 | 2 Top Stocks to Watch at ASCO 2019

2019-05-16 09:00:00 | Blueprint Medicines Announces Data Presentations at ASCO and EHA Meetings from Registration-Enabling Clinical Trials of Avapritinib and BLU-667 Across Multiple Patient Populations

2019-05-15 10:16:00 | 3 Stocks With Big News Coming at ASCO 2019

2019-05-14 11:12:30 | How Much is Blueprint Medicines Corporation's NASDAQ:BPMC CEO Getting Paid?

2019-05-13 08:44:12 | Blueprint Medicines BPMC Q1 Earnings & Sales Lag Estimates

2019-05-10 08:35:30 | Edited Transcript of BPMC earnings conference call or presentation 9-May-19 12:30pm GMT

2019-05-10 08:24:03 | Blueprint Medicines BPMC Q1 2019 Earnings Call Transcript

2019-05-09 08:35:12 | Blueprint Medicines BPMC Reports Q1 Loss, Misses Revenue Estimates

2019-05-09 07:23:27 | Blueprint Medicines: 1Q Earnings Snapshot

2019-05-09 07:00:00 | Blueprint Medicines Reports First Quarter 2019 Financial Results

2019-05-08 10:38:02 | Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More

2019-05-08 08:00:00 | Blueprint Medicines to Present at Bank of America Merrill Lynch 2019 Health Care Conference

2019-05-07 08:03:21 | See what the IHS Markit Score report has to say about Blueprint Medicines Corp.

2019-05-02 08:00:00 | Blueprint Medicines to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019

2019-04-30 08:04:10 | See what the IHS Markit Score report has to say about Blueprint Medicines Corp.

2019-04-29 12:59:42 | Did Hedge Funds Drop The Ball On Blueprint Medicines Corporation BPMC ?

2019-04-24 10:33:02 | Earnings Preview: Blueprint Medicines BPMC Q1 Earnings Expected to Decline

2019-04-03 08:16:00 | 3 Small-Cap Biotech Stocks to Watch Now

2019-04-02 16:01:00 | Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock

2019-04-01 08:43:12 | Blueprint Medicines BPMC Looks Good: Stock Adds 5.7% in Session

2019-03-30 10:12:31 | If You Had Bought Blueprint Medicines NASDAQ:BPMC Stock Three Years Ago, You Could Pocket A 337% Gain Today

2019-03-28 20:40:00 | Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock

2019-03-28 11:18:03 | Blueprint Medicines Expediates Filings for Key Candidates

2019-03-27 16:03:00 | Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock

2019-03-27 16:00:00 | Blueprint Medicines Announces Accelerated Regulatory Submission Plans and Recent Clinical Progress

2019-03-27 14:47:06 | 5 Cancer-Fighting Stocks to Boost Portfolio Gains

2019-03-23 12:14:00 | 3 Cancer Treatment Stocks to Buy in March

2019-03-05 08:01:00 | Blueprint Medicines to Present at 39th Annual Cowen & Co. Health Care Conference

2019-03-01 07:10:00 | Market Trends Toward New Normal in ITT, Palo Alto Networks, Enterprise Products Partners, Blueprint Medicines, Lincoln Electric, and NewMarket — Emerging Consolidated Expectations, Analyst Ratings

2019-02-26 18:12:32 | Edited Transcript of BPMC earnings conference call or presentation 26-Feb-19 1:30pm GMT

2019-02-26 13:16:16 | Blueprint Medicines Corp BPMC Q4 2018 Earnings Conference Call Transcript

2019-02-26 07:00:00 | Blueprint Medicines Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-21 16:00:00 | 3 Top Healthcare Stocks to Buy in February

2019-02-19 08:00:00 | Blueprint Medicines to Report Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019

2019-02-13 10:31:03 | Earnings Preview: Blueprint Medicines BPMC Q4 Earnings Expected to Decline

2019-02-08 08:04:50 | See what the IHS Markit Score report has to say about Blueprint Medicines Corp.

2019-02-07 16:01:00 | Blueprint Medicines to Present at Upcoming Investor Conferences in February

2019-01-29 08:05:09 | See what the IHS Markit Score report has to say about Blueprint Medicines Corp.

2019-01-24 09:00:00 | Three Companies Using AI and Innovation to Lead Healthcare Sector

2019-01-17 15:50:50 | Lilly's 10-Day Sprint For Loxo Could Put Other Names On The Table

2019-01-17 15:50:50 | Lilly's 10-Day Sprint For Loxo Could Put Other Names On The Table

2019-01-15 08:03:26 | See what the IHS Markit Score report has to say about Blueprint Medicines Corp.